US biotech Tract Bio has appointed Chris Galloway as chief medical and development officer, as it prepares for an ...

If approved, MCO-010 would be the first treatment to restore vision in legally blind RP patients without needing genetic ...

Swiss clinical-stage CNS disease specialist Synendos Therapeutics has named Dr George Garibaldi as its chief medical officer ...

USA-based Uniquity Bio has appointed industry veteran Will Kane as its president and chief executive. The clinical-stage drug ...

San Diego, USA-based Neurocrine Biosciences on Monday reported new positive data from the Phase III CAHtalyst Adult study of ...

US biotech major Vertex Pharmaceuticals (Nasdaq: VRTX) has reached a wide-ranging reimbursement deal with NHS England for ...

Indian drugmaker Sun Pharmaceutical Industries together with its subsidiaries announced that further to its intimation dated ...

A quiet shift with potentially big implications for cancer drug access is underway in the UK. In June, the country’s health ...

China’s vaccine landscape is shifting after local biotech Xiamen Innovax Biotech unveiled the country’s first domestically ...

Japan’s largest pharma company Taked today announced that all primary and secondary endpoints were met in two Phase III ...

China-based biotech CARsgen Therapeutics (HKEX: 2171) has strengthened its grip on intellectual property in the CAR-T space ...

South Korean biotech Illimis Therapeutics has raised 58 billion won ($42 million) in a series B round to advance its GAIA ...